In this section, we refer to skin malignancies in the detailed molecular mechanism of STING-mediated anti-tumor immunity, such as melanoma, squamous cell carcinoma, Merkel cell carcinoma, and adult T-cell leukemia/lymphoma. Here, STING1 is linked to lymphoma.